Surgery Medical News about stent

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Drug-eluting stent in malignant biliary obstruction
Journal of Hepato-Biliary-Pancreatic Surgery, 07/01/09

Lee DK - The authors expect and hope DES will work effectively for tumor cells in diverse ways and, more importantly, will prolong stent patency and the patients’ survival periods. But considerable investigation and a clinical study of DES will be required to achieve these goals.

Exclusive Author Commentary
Dong Ki Lee, 07/01/09

I will continue to develope the DES effectivity by prolonging the drug release. And examine the various chemotherapeutic agent to achieve the ideal DES for the patients with malignat bile duct obstruction. I shall expedite the availability of the DES to the market.

<< Previous
Management of life-threatening haemoptysis in an area of high...

Next >>
Covered metallic stents in the management of malignant and benign...